Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph Pidala

Showing results (61-70 of 198) with videos related to

Pageof 20
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 17, 2018
The Anatomic Distribution of Skin Involvement in Patients with Incident Chronic Graft-versus-Host DiseaseJocelyn S Gandelman, John Zic, Anna K Dewan, et al.
Haematologica|May 14, 2011
Sirolimus demonstrates activity in the primary therapy of acute graft-versus-host disease without systemic glucocorticoidsJoseph Pidala, Marcie Tomblyn, Taiga Nishihori, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 29, 2025
HSR25-166: Linking COVID-Related Distress and Mental Health Service Utilization Among Allogeneic Hematopoietic Stem Cell Transplant PatientsHalle R Smith, Marilyn Horta, Skye O Dougan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 28, 2014
Conditioning chemotherapy dose adjustment in obese patients: a review and position statement by the American Society for Blood and Marrow Transplantation practice guideline committeeJoseph Bubalo, Paul A Carpenter, Navneet Majhail, et al.
American Journal of Hematology|October 5, 2010
Allogeneic hematopoietic cell transplantation for myelofibrosis: a 10-year experience at single institutionTaiga Nishihori, Janelle Perkins, Jongphil Kim, et al.
Blood|March 1, 2011
Patient-reported quality of life is associated with severity of chronic graft-versus-host disease as measured by NIH criteria: report on baseline data from the Chronic GVHD ConsortiumJoseph Pidala, Brenda Kurland, Xiaoyu Chai, et al.
The Journal of Pathology. Clinical Research|February 1, 2017
A combined biomarker and clinical panel for chronic graft versus host disease diagnosisJoseph Pidala, Tara K Sigdel, Anyou Wang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 26, 2018
Proinflammatory Cytokine and Adipokine Levels in Adult Unrelated Marrow Donors Are Not Associated with Hematopoietic Cell Transplantation OutcomesLucie M Turcotte, Tao Wang, Michael T Hemmer, et al.
Blood|November 4, 2015
Predictors of survival, nonrelapse mortality, and failure-free survival in patients treated for chronic graft-versus-host diseaseJeanne Palmer, Xiaoyu Chai, Joseph Pidala, et al.
American Journal of Epidemiology|May 5, 2017
Tools for the Precision Medicine Era: How to Develop Highly Personalized Treatment Recommendations From Cohort and Registry Data Using Q-LearningElizabeth F Krakow, Michael Hemmer, Tao Wang, et al.
Pageof 20

Showing results (61-70 of 198) with videos related to

Sort By:
Pageof 20
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 17, 2018
The Anatomic Distribution of Skin Involvement in Patients with Incident Chronic Graft-versus-Host DiseaseJocelyn S Gandelman, John Zic, Anna K Dewan, et al.
Haematologica|May 14, 2011
Sirolimus demonstrates activity in the primary therapy of acute graft-versus-host disease without systemic glucocorticoidsJoseph Pidala, Marcie Tomblyn, Taiga Nishihori, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 29, 2025
HSR25-166: Linking COVID-Related Distress and Mental Health Service Utilization Among Allogeneic Hematopoietic Stem Cell Transplant PatientsHalle R Smith, Marilyn Horta, Skye O Dougan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 28, 2014
Conditioning chemotherapy dose adjustment in obese patients: a review and position statement by the American Society for Blood and Marrow Transplantation practice guideline committeeJoseph Bubalo, Paul A Carpenter, Navneet Majhail, et al.
American Journal of Hematology|October 5, 2010
Allogeneic hematopoietic cell transplantation for myelofibrosis: a 10-year experience at single institutionTaiga Nishihori, Janelle Perkins, Jongphil Kim, et al.
Blood|March 1, 2011
Patient-reported quality of life is associated with severity of chronic graft-versus-host disease as measured by NIH criteria: report on baseline data from the Chronic GVHD ConsortiumJoseph Pidala, Brenda Kurland, Xiaoyu Chai, et al.
The Journal of Pathology. Clinical Research|February 1, 2017
A combined biomarker and clinical panel for chronic graft versus host disease diagnosisJoseph Pidala, Tara K Sigdel, Anyou Wang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 26, 2018
Proinflammatory Cytokine and Adipokine Levels in Adult Unrelated Marrow Donors Are Not Associated with Hematopoietic Cell Transplantation OutcomesLucie M Turcotte, Tao Wang, Michael T Hemmer, et al.
Blood|November 4, 2015
Predictors of survival, nonrelapse mortality, and failure-free survival in patients treated for chronic graft-versus-host diseaseJeanne Palmer, Xiaoyu Chai, Joseph Pidala, et al.
American Journal of Epidemiology|May 5, 2017
Tools for the Precision Medicine Era: How to Develop Highly Personalized Treatment Recommendations From Cohort and Registry Data Using Q-LearningElizabeth F Krakow, Michael Hemmer, Tao Wang, et al.
Pageof 20